EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEvangelisches Krankenhaus Düsseldorf

About this trial

Safety and efficacy of EDEE (EUS-directed transenteric ERCP)

Eligibility criteria

Qualifiers

signed consent form

Indication for an EDEE

Age >18 years

Disqualifiers

Age < 18 years

Trial design

Treatments tested in this trial

  • EDEE (EUS-directed transenteric ERCP)

Treatment groups

40 Participants
are divided into 1 treatment group